DRG-Physician-pharma rep engagement has declined significantly in the past year

SHORT READ: According to DRG “physician-pharma rep engagement has declined significantly in the past year, with in-person interaction, traditionally pharma’s main commercial lever, accounting for most of the drop. Remote engagement is not yet picking up the slack. Interest in remote use has declined as the novelty has worn off, but remains substantial”.

Continue reading

Why the public doesn’t​ trust big pharma

SUMMARY: The CEOs of Abbvie, Bristol-Myers Squibb, Merck, Pfizer, Roche Pharmaceuticals, and Sanofi each contributed $15,600 to McConnell’s joint fundraising committee in the third quarter. Novo Nordisk Executive Vice President Doug Langa chipped in $10,000, Amgen CEO Robert Bradway gave $7,500, and Celgene CEO Mark Alles contributed $5,000. McConnell’s opposition to the bill comes after he had an exceptional quarter of fundraising from executives and PACs of pharmaceutical companies that could be forced to reduce the prices of their drugs under Medicare. Sigh..

Continue reading

Drop in the share of physicians seeing reps in-person

KEY DATA: According to DRG research share of physicians seeing reps in-person dropped from 67% to 54%. Most notably, physician respondents highlighted a time crunch as the primary cause for less in-person time, with increased patient loads, EHR maintenance and time spent on other bureaucratic tasks resulting in less available time to meet with pharma representatives.

Continue reading

Private health insurers have contributed nothing of value to the American healthcare system

SUMMARY: Los Angeles Times…”The most perplexing aspect of our current debate over healthcare and health coverage is the notion that Americans love their health insurance companies. The truth is that private health insurers have contributed nothing of value to the American healthcare system. Instead, they have raised costs and created an entitled class of administrators and executives who are fighting for their livelihoods, using customers’ premium dollars to do so.” Ouch

Continue reading

Stop blaming pharma for your bad habit​s

KEY SUMMARY: The idea that pharma “likes to keep people sick” is an excuse for poor lifestyle choices. The percentage of people who are overweight or obese soared from 22 percent in 1994 to 42 percent in 2016, nearly doubling. Obesity impacts where consumers spend their money. An individual with a body mass index (BMI) that’s considered “obese” spends 42 percent more on direct health care costs than adults who are a healthy weight.

Continue reading

Cancer death rates declining but

  • Death rates from cancer declined by 19%. Death rates from heart disease declined by 22% until 2011 but increased by 4% from then to 2017.
  • Cancer was still the major killer and had a higher death rate compared to heart disease. In fact, the cancer mortality rate in 2017 was nearly 40% higher than that for heart disease.
  • There is now strong evidence excessive weight is the cause of at least 12 cancers, five more than when the last WCRF recommendations were published in 2007.
  • Obesity is likely to overtake smoking as the “number one risk factor for cancer” within decades.
Continue reading